When fentanyl deaths hit a county, buprenorphine treatment rises 5 to 17 percent within 1–2 quarters, but only where prescribing capacity already exists, from Siegal, Gupta, Aalsma, Crystal, Miles, Samples, Campbell, Simon, and Liccardo Pacula www.nber.org/papers/w35648
Nicole Siegal
@nicolesiegal.bsky.social
Health Economist | Postdoc at the O’Neill School of Public and Environmental Affairs at Indiana University https://sites.google.com/view/nicolesiegal
So excited to share my new paper in AJHE! States without triplicate prescription laws saw persistently higher Republican vote shares in presidential elections following OxyContin's release. Thank you to all who provided feedback along the way!
New! @nicolesiegal.bsky.social examines the relationship between early exposure to the opioid epidemic and US voting behavior. State policies tied to greater opioid exposure were followed by lasting shifts in presidential voting toward the GOP. www.journals.uchicago.edu/doi/epdf/10.1086/742007
New @jamanetworkopen.com: Recent Medicaid expansions showed significant all-payer buprenorphine treatment increases while earlier expansions did not - suggesting current policy environment enhances effectiveness With @drsumedhagupta.bsky.social, Kosali Simon, & team doi.org/10.1001/jama...
Early vs Recent Medicaid Expansion and Buprenorphine Dispensing
This cross-sectional study evaluates the association of Medicaid expansion with buprenorphine treatment rates and tests whether post-2018 expansions differed from earlier ones.
jamanetwork.com